Call for Nominations: Innovations in Regulatory Science Awards
Reagan-Udall Foundation for the Food and Drug Administration is seeking nominations through June 14, 2019, for its third annual Innovations in Regulatory Science Awards. These Awards honor outstanding achievements of individuals and organizations that have made distinguished contributions to regulatory science and policy.
The Awards will be presented in three categories this year. Full criteria is detailed in the nomination form (download below).
Leadership Award recognizes an individual’s significant contributions, national leadership, and service in the field of regulatory science and public health.
Innovation Award is for an individual, team, or organization that has improved public health through a specific innovation in regulatory issues or science.
Advocacy/Policy Award, our new award category, is for an individual, group, or organization in recognition of significant policy achievements that advance regulatory science and have a direct impact on the public.
Nomination Process for 2019
Nomination deadline extended to June 14, 2019
Anyone can submit a nomination. Self-nomination is allowed. Foundation Board members and staff are not eligible to be nominated.
To submit a nomination, please provide the following documents.
1. Nomination form
The nomination form includes instructions and full award criteria. Please complete in its entirety, specifying the award category and providing contact information for the nominee and the nominator.
2. Justification statement
A 1,000-word narrative that describes the nominee’s contributions, highlighting the achievements or activities that support criteria for the award.
3. Supporting document(s)
A professional and/or personal biography or a curriculum vitae of the nominee.
Submit the nomination package electronically by emailing email@example.com or you may send the hard copy to:
Executive Assistant to Executive Director
Reagan-Udall Foundation for the FDA
1900 L Street NW, Ste 835
Washington, D.C., 20036
2018 - Richard Pazdur, MD, Director of the FDA’s Oncology Center of Excellence
2017 - Janet Woodcock, MD, Director of the FDA Center for Drug Evaluation and Research
2018 - Robert O’Neill, PhD, former Senior Statistical Adviser, Center for Drug Evaluation and Research
2018 - Clinical Trials Transformation Initiative
2017 - Patrick Ryan, PhD, Senior Director and Head of Epidemiology Analytics at Janssen Research and Development